View As PDF >> Drug development from compound screening through commercial launch for pharmaceutical companies involves long lead times, highly complex and inflexible capital equipment, and high failure rates.1 Project owners make decisions with high uncertainty for the product’s market potential as well as uncertain and complex technologies. Late-stage clinical trial failures...